The store will not work correctly when cookies are disabled.
3-(4-(4-(4-Fluorophenyl)piperazin-1-yl)butyl)-5-phenyl-1,3,4-oxadiazol-2(3H)-one
ID: ALA4567801
PubChem CID: 155560722
Max Phase: Preclinical
Molecular Formula: C22H25FN4O2
Molecular Weight: 396.47
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1oc(-c2ccccc2)nn1CCCCN1CCN(c2ccc(F)cc2)CC1
Standard InChI: InChI=1S/C22H25FN4O2/c23-19-8-10-20(11-9-19)26-16-14-25(15-17-26)12-4-5-13-27-22(28)29-21(24-27)18-6-2-1-3-7-18/h1-3,6-11H,4-5,12-17H2
Standard InChI Key: IOAXVKXNLDSFFC-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
22.8469 -7.2267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8458 -8.0463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5538 -8.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2635 -8.0458 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2607 -7.2231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5520 -6.8179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5501 -6.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.2098 -5.5184 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.9549 -4.7420 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.1377 -4.7444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.8876 -5.5224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.6553 -4.0848 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.6602 -4.3253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3720 -4.7268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0755 -4.3112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7873 -4.7127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4909 -4.2970 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.2001 -4.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9016 -4.2916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8976 -3.4740 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.1860 -3.0704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4783 -3.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6028 -3.0610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3090 -3.4687 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0137 -3.0564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0091 -2.2384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2938 -1.8344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5921 -2.2490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7137 -1.8244 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
11 7 1 0
6 7 1 0
10 12 2 0
9 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.47 | Molecular Weight (Monoisotopic): 396.1962 | AlogP: 3.24 | #Rotatable Bonds: 7 |
Polar Surface Area: 54.51 | Molecular Species: NEUTRAL | HBA: 6 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.28 | CX LogP: 4.36 | CX LogD: 3.43 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.57 | Np Likeness Score: -1.92 |
References
1. Zampieri D, Fortuna S, Calabretti A, Romano M, Menegazzi R, Schepmann D, Wünsch B, Collina S, Zanon D, Mamolo MG.. (2019) Discovery of new potent dual sigma receptor/GluN2b ligands with antioxidant property as neuroprotective agents., 180 [PMID:31319263] [10.1016/j.ejmech.2019.07.012] |